Levothyroxine in Pregnancy Did Not Affect Neonatal Admission Rates
Women being treated with levothyroxine were administered a daily morning dose throughout pregnancy starting 4-8 days after her first prenatal visit.
Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.
Investigators reviewed cases of patients with multiple sclerosis treated with alemtuzumab to determine the type and frequency of thyroid dysfunction.
The device is indicated for ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including musculoskeletal, vascular, small parts (breast, thyroid), and lung imaging.